Medical devices industry M&A deals in Q3 2020 total $91.21bn globally

18 November 2020 (Last Updated November 18th, 2020 03:12)

Medical devices industry M&A deals in Q3 2020 total $91.21bn globally

Total medical devices industry M&A deals in Q3 2020 worth $91.21bn were announced globally, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the code below into your website to display the chart.

The value marked an increase of 3832.5% over the previous quarter and a rise of 1534.1% when compared with the last four-quarter average, which stood at $5.58bn.

Comparing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $89.65bn. At the country level, the US topped the list in terms of deal value at $89.65bn.

In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.

The top country in terms of M&A deals activity in Q3 2020 was the US with 57 deals, followed by the UK with eight and Germany with seven.

In 2020, as of the end of Q3 2020, medical devices M&A deals worth $96.13bn were announced globally, marking an increase of 207.2% year on year.

Medical devices industry M&A deals in Q3 2020: Top deals

The top five medical devices industry M&A deals accounted for 96.4% of the overall value during Q3 2020.

The combined value of the top five medical devices M&A deals stood at $87.9bn, against the overall value of $91.21bn recorded for the month.

The top five medical devices industry deals of Q3 2020 tracked by GlobalData were:

1) Vilex in Tennessee’s $62bn acquisition of DT MedTech

2) The $16.4bn acquisition of Varian Medical Systems by Siemens Healthineers

3) Illumina’s $8bn acquisition of Grail

4) The $780m acquisition of Advanced Instruments by Patricia Industries

5) The merger of Healthcare Merger and SOC Telemed for $720m.

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.